Pharmacovigilance

The XEVMPD, one year on – An industry viewpoint

Related Full Issue: 
Type of Article: 
Focus
Non Member Download: 
Non member cannot download
Related content:

The impact of the changes to the PSUR legislation

Related Full Issue: 
Type of Article: 
Focus
Non Member Download: 
Non member cannot download
Related content:

The EU Pharmacovigilance Risk Assessment Committee: First year experiences

Related Full Issue: 
Type of Article: 
Focus
Non Member Download: 
Non member can download
Related content:

The Pharmaceutical Package, one year on – Experiences of a national competent authority

Related Full Issue: 
Type of Article: 
Focus
Non Member Download: 
Non member cannot download
Related content: